| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-03-1301 |
| P698 | PubMed publication ID | 14744769 |
| P50 | author | Yung-Ming Jeng | Q56383907 |
| Min-Liang Kuo | Q56588181 | ||
| Men-Luh Yen | Q57153134 | ||
| P2093 | author name string | Jin-Yuan Shih | |
| Pan-Chyr Yang | |||
| Jen-Liang Su | |||
| Chang-Yao Hsieh | |||
| Lin-Hung Wei | |||
| Cheng-Chi Chang | |||
| P2860 | cites work | VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| adenocarcinoma | Q356033 | ||
| lymphangiogenesis | Q6708231 | ||
| P304 | page(s) | 554-564 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma | |
| P478 | volume | 64 |
| Q41544143 | 25-Hydroxycholesterol exerts both a cox-2-dependent transient proliferative effect and cox-2-independent cytotoxic effect on bovine endothelial cells in a time- and cell-type-dependent manner |
| Q90397552 | A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer |
| Q39146947 | A practical and sensitive method of quantitating lymphangiogenesis in vivo |
| Q38101107 | Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways. |
| Q37437576 | Basic fibroblast growth factor promotes VEGF-C-dependent lymphangiogenesis via inhibition of miR-381 in human chondrosarcoma cells. |
| Q37392868 | CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells |
| Q39633227 | COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway |
| Q80375992 | COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma |
| Q24651871 | COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer |
| Q40502299 | COX2-related multicentric mixed-type Castleman's disease in a young man. |
| Q34346431 | CSNK1E/CTNNB1 are synthetic lethal to TP53 in colorectal cancer and are markers for prognosis |
| Q39377146 | Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression |
| Q90183893 | Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients |
| Q36238149 | Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma |
| Q36735345 | Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer |
| Q33314445 | Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer |
| Q35810119 | Crosstalk of oncogenic and prostanoid signaling pathways |
| Q34305332 | Cyclooxygenase-1 and -2: molecular targets for cervical neoplasia. |
| Q30436782 | Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells |
| Q46968408 | Cyclooxygenase-2 expression is associated with VEGF-C and lymph node metastases in gastric cancer patients |
| Q36609908 | Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer |
| Q34637939 | Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme |
| Q40005941 | Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells. |
| Q34414026 | Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. |
| Q28072448 | Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer |
| Q52659990 | Disrupted Balance of MMPs/TIMPs in Gastric Carcinogenesis-Paradoxical Low MMP-2 Expression in Tumor and Stromal Compartments as a Potential Marker of Unfavorable Outcome. |
| Q33890819 | EP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway |
| Q34733346 | Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer |
| Q34141566 | Effect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells |
| Q92852137 | Establishment of cervical dynamic and static imbalance models and preliminary study on the mechanism of cervical degeneration in rats |
| Q35651481 | Expression of COX-2 and HER-2 in colorectal cancer and their correlation |
| Q47131381 | Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer. |
| Q34567287 | Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications |
| Q38637559 | Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers |
| Q39692993 | In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate |
| Q64100498 | Inflammation and Lymphatic Function |
| Q34117518 | Inflammatory lymphangiogenesis in postpartum breast tissue remodeling |
| Q27331781 | Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension |
| Q34167898 | Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNA |
| Q35805617 | Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome |
| Q34340057 | Interleukin-1β expression is required for lysophosphatidic Acid-induced lymphangiogenesis in human umbilical vein endothelial cells |
| Q39957663 | Involvement of non-conserved residues important for PGE2 binding to the constrained EP3 eLP2 using NMR and site-directed mutagenesis |
| Q40040603 | Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications |
| Q37040086 | Leptin promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-27b in human chondrosarcoma cells |
| Q38190359 | Lymphangiogenesis and lymphatic vessel remodelling in cancer |
| Q42160346 | Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C. |
| Q26797490 | Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis |
| Q26778332 | Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer |
| Q38161374 | Lymphatic vessels: new targets for the treatment of inflammatory diseases |
| Q33555154 | Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches |
| Q37475323 | MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2. |
| Q40264460 | Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway |
| Q37969041 | Modulation of lymphangiogenesis: a new target for aspirin and other nonsteroidal anti-inflammatory agents? A systematic review |
| Q80416374 | Molecular mechanisms of lymphangiogenesis |
| Q37943405 | Multifaceted link between cancer and inflammation |
| Q36009237 | Myeloid cells and lymphangiogenesis |
| Q24338984 | N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity |
| Q82722866 | Nerve growth factor-beta expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma |
| Q39462734 | Notch2-induced COX-2 expression enhancing gastric cancer progression |
| Q81424350 | Overexpression of cyclooxygenase-2 in gastric cancer correlates with the high abundance of vascular endothelial growth factor-C and lymphatic metastasis |
| Q35929801 | PC4 induces lymphangiogenesis dependent VEGF-C/VEGF-D/VEGFR-3 axis activation in lung adenocarcinoma |
| Q36851512 | Potential therapeutic strategies for lymphatic metastasis |
| Q34473395 | Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells |
| Q36611067 | Prostaglandin E2 receptor distribution and function in the gastrointestinal tract |
| Q28569432 | Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts |
| Q30430640 | Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells |
| Q57382063 | Pulmonary Vascular Endothelial Growth Factor-C in Development and Lung Injury in Preterm Infants |
| Q50950470 | Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography. |
| Q54372705 | Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema. |
| Q34400103 | Screening and identification of dietary oils and unsaturated fatty acids in inhibiting inflammatory prostaglandin E2 signaling in fat stromal cells |
| Q42251992 | Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression |
| Q39094265 | Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells |
| Q46582619 | Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer |
| Q36367559 | Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer |
| Q58742403 | The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis |
| Q35722400 | The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors |
| Q24307613 | The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells |
| Q36339264 | The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway. |
| Q38054491 | The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis |
| Q39037809 | Thromboxane A2 exerts promoting effects on cell proliferation through mediating cyclooxygenase-2 signal in lung adenocarcinoma cells |
| Q35931998 | Tumour angiogenesis, vascular biology and enhanced drug delivery |
| Q37687452 | Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma |
| Q42483046 | Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression |
| Q54220504 | VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. |
| Q36962844 | WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells |
Search more.